Latest Biotechnology, Pharmaceutical and Healthcare News from PharmPro

19:01 EDT 20th August 2017 | BioPortfolio

Here are the most relevant search results for "PharmPro" found in our extensive news archives from over 250 global news sources.

More Information about PharmPro on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PharmPro for you to read. Along with our medical data and news we also list PharmPro Clinical Trials, which are updated daily. BioPortfolio also has a large database of PharmPro Companies for you to search.

Showing News Articles 1–25 of 4,200+ from PharmPro

Friday 18th August 2017

Going Global? How to Get Your Business Ready for a Global Audience

ArticleArmed with the right people, strategy, process, and technology, life sciences organizations can reap the rewards of successful global expansion.

Pfizer Drug Approved for Adults with Acute Lymphoblastic Leukemia

NewsPfizer receives U.S. FDA approval for Besponsa (inotuzumab ozogamicin). Besponsa is the only CD22-directed antibody-drug conjugate indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

10-Year, $1B Life Sciences Plan Bears Fruit in Massachusetts

NewsA initiative, signed by former Democratic Gov. Deval Patrick, committed Massachusetts to spending $1 billion over 10 years to jump-start the life sciences sector — attracting the best minds, research facilities, and the venture capital funding.

Negotiations to Commercialize Noctiva in U.S. and Canada Underway

NewsAvadel Pharmaceuticals enters into exclusive negotiations with Serenity Pharmaceuticals for Noctiva. If either company terminates negotiations without cause, it must pay the other $10 million. The exclusive period is expected to close on or before September 7.

Study Showed Lowering LDL-C with Repatha Did Not Impair Cognition

NewsRepatha (evolocumab) Phase 3 cognitive function study results published in The New England Journal of Medicine. The results from one of the largest cognitive function trials support the Repatha safety profile.

Mylan $465M Settlement with DOJ Over EpiPen Medicaid Issue Finalized

NewsMylan finalizes settlement agreement on Medicaid rebate classification for EpiPen Auto-Injector. The question was whether the EpiPen products were properly classified as a non-innovator drug.

FDA Awards $403k to Treat Autoimmune-Mediated Condition

NewsProtalex awarded grant from FDA Office of Orphan Products Development to foster clinical development of PRTX-100 for the treatment of immune thrombocytopenia.

FDA Awards $403k to Help Develop Treatment for Autoimmune-Mediated Condition

NewsProtalex awarded grant from FDA Office of Orphan Products Development to foster clinical development of PRTX-100 for the treatment of immune thrombocytopenia.

China Healthcare Group Bolstering R&D with Cloud Implementation

NewsFosun Pharma selects Medidata’s unified platform for clinical development in China. Healthcare group adopts cloud technology to bring operational efficiencies to its R&D programs.

Thursday 17th August 2017

Deep-Sea Sponges: Home to the next Generation of Antimicrobials?

NewsA team of scientists from the University of Plymouth are identifying and developing potential new antimicrobials produced by the microbiome of sponges which live deep beneath the ocean surface.

This Desert Shrub Could Be the next Treatment for Deadly Parasites

NewsCU Anschutz and UC San Diego researchers find creosote bush could treat deadly infections.Contributed Author: 

U.S. Commercialization Agreement for FDA-Approved GERD Treatment

NewsRedHill Biopharma announces U.S. commercialization agreement for FDA-approved GI product Esomeprazole Strontium Delayed-Release Capsules.

FDA-Approved, At-Home Conception Kit Available in the U.S.

NewsConceivex and sign national distribution agreement.

Experimental Drug + Cisplatin Found to Kill Cancer Cells

NewsCombination of traditional chemotherapy, new drug kills rare cancer cells in mice.

More Than 200 Potential Jurors Excused from Shkreli's Trial

NewsHarper's Magazine published transcripts of the jury selection from the trial, occurring over three days in June. The jurors were united one thing: Their dislike of Shkreli.

GSK & Insilico to Research Use of Artificial Intelligence in Drug Discovery

NewsInsilico establishes collaboration with GSK to discover novel biological targets and molecules.

Wednesday 16th August 2017

$10M Dedicated to Reducing Unsafe Opioid Prescribing & Improving Pain Management

NewsPCORI Board approves $10 million for new studies on reducing unsafe opioid prescribing.Contributed Au

Shuttle Pharmaceuticals & POLA Pharma License U.S. Rights to Doranidazole

NewsShuttle Pharmaceuticals and POLA Pharma Inc. agree to license U.S. rights to doranidazole.

Study of Cannabinoid Drug for Osteoarthritis Continues Even After Failed Phase 2 Trial

NewsZynerba Pharmaceuticals announces that results from Phase 2 STOP trial support continued development of ZYN002 in osteoarthritis.

New Chip Technology Could Monitor Drug Levels & Toxicology

NewsMIMETAS develops high-throughput gut-on-a-chip technology in collaboration with pharmaceutical company.

Opdivo and Yervoy Combo Misses on Progression-Free Survival Endpoint

NewsBristol-Myers Squibb announces topline results from CheckMate -214, a Phase 3 study of Opdivo in combination with Yervoy in intermediate and poor-risk patients with previously untreated advanced or metastatic renal cell carcinoma.

Barcode Quality: Ignore It at Your Peril

ArticleSince barcode performance affects business performance, it’s important to know the difference between barcode reading (also called scanning) barcode grading (a.k.a. verifying).

INTERPHEX Live: Regulatory Aspects of Continuous Bioprocessing

VideosToday’s regulators encourage the incorporation of continuous manufacturing in operations. Learn the U.S. GMPs’ definitions of batch vs. continuous processing and how the physical and chemical aspects impact process in this INTERPHEX Live video.

INTERPHEX Live: Quality Metrics/Quality Agreements

VideosWhen negotiating quality agreements with a client, it’s important to ensure team members are aligned — understanding risk assessments in that early integration period. But how do personalization and other changes factor in? Afton Scientific, Catalent, and CRB give us the answer.

INTERPHEX Live: Enabling Technologies to Streamline Operations

VideosThe training period for pharmaceutical professionals can take anywhere from weeks to months. However, is efficient training enough? Learn where technologies and highly-trained personnel overlap to streamline operations in this INTERPHEX Live video with Merck Biodevelopment.

Quick Search

News Quicklinks